Evaluating Biopharma

Evaluating Biopharma
  • 5.0 (4)
  • CIENCIAS DE LA VIDA
  • CADA MES
Evaluating Biopharma

Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.

  1. Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance

    12 NOV

    Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance

    In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and how the industry can achieve them. With 30 years of experience, Endicott has a deep understanding of training AI and ML models, particularly when patient data is included, and offers advice on how to navigate the challenges of data governance and provenance in the near-term future. Links from ...

    17 min
  2. Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech

    8 OCT

    Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech

    In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company to address technology gaps, why it is beneficial to collaborate with competitors (instead of going against each other), and the challenges encountered when planning to de-risk portfolios in advance. Major also talks about how he approaches funding, the best practices and lessons he learned about time-to-exit strategies, and h...

    35 min
  3. Episode: 21 - How AI is Changing the Antibody R&D Game

    10 SEPT

    Episode: 21 - How AI is Changing the Antibody R&D Game

    In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibody R&D field, how companies are using AI to generate better sequences and improve efficacy, and methods on approaching regulators and tackling regulatory challenges. Arulanandam also talks about how he got started in biotech, getting therapies to underserved patient populations, and his thoughts on the promise of anti...

    32 min
  4. Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix

    18 JUL

    Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix

    In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief human resources officer at Prime Medicine, about the upcoming Talent in Biopharma Leadership workshop at the 2024 Bioprocessing Summit. Their conversation covers a wide variety of topics about talent management, including prioritizing talent retention, building agility into talent acquisition strategies, the importance of brand...

    20 min
  5. Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies

    11 JUN

    Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies

    In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets them apart from other therapeutics in terms of their processes. Vives also talks about the top characteristics of good starting materials and particular modes of handling logistics. He also delves into correlating a particular donor for a certain patient and shares where he sees the future of cell ...

    17 min
  6. Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts

    14 MAY

    Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts

    In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about bispecific antibodies. Dr. Schmidt goes into detail about current trends (from a CRO’s perspective) regarding the discovery and development phases of bispecific antibodies, why they are being made, and potential manufacturing issues. He also discusses the future of bispecific antibodies and concerns over intellectual property immunity influencing consistency and production. E...

    24 min
  7. Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin

    12 MAR

    Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin

    In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful program management. Martin shares his mental checklist of must-haves to ensure a successful start, techniques on what to do when things fall off-track, and the keys to continuous success as the program is running. He also provides advice for listeners who may have newer programs or are new to program management, as well as the “...

    23 min
  8. Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma

    12 MAR

    Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma

    In this episode of Evaluating Biopharma, host Ben Locwin speaks with Brian Tham, principal consultant at Peregrine Bio, LLC, on how various projects are run in the pharmaceutical industry, how to improve the outcome and processes of projects, and how to continue improving processes and operational excellence. They also delve into the history of how the car manufacturing industry influenced the quality management models and standards of the biotech and pharmaceutical industries. Finally, Tham ...

    21 min
Ver todo (24)

Calificaciones y reseñas

5
de 5
4 calificaciones

Acerca de

Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.

Información

  • Creador
    Evaluating Biopharma
  • Años de actividad
    2022 - 2024
  • Episodios
    24
  • Clasificación
    Apto
  • Copyright
    © 2024 Evaluating Biopharma
  • Mostrar sitio web
    Evaluating Biopharma

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá